CID 491265

Schembl14032180

Structural Information

Molecular Formula
C30H29N9O2S
SMILES
C1CCC(CC1)N2C3=C(C=C(C=C3)C(=O)N[C@@H](CC4=CC=C(C=C4)C5=NNN=N5)C6=CSC(=N6)N)N=C2C7=COC=C7
InChI
InChI=1S/C30H29N9O2S/c31-30-34-25(17-42-30)23(14-18-6-8-19(9-7-18)27-35-37-38-36-27)33-29(40)20-10-11-26-24(15-20)32-28(21-12-13-41-16-21)39(26)22-4-2-1-3-5-22/h6-13,15-17,22-23H,1-5,14H2,(H2,31,34)(H,33,40)(H,35,36,37,38)/t23-/m0/s1
InChIKey
DZZMYZOJGVXIOS-QHCPKHFHSA-N
Compound name
N-[(1S)-1-(2-amino-1,3-thiazol-4-yl)-2-[4-(2H-tetrazol-5-yl)phenyl]ethyl]-1-cyclohexyl-2-(furan-3-yl)benzimidazole-5-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

8
Patents

579.2165 Da
Monoisotopic Mass

4.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 580.22378 212.5
[M+Na]+ 602.20572 219.2
[M-H]- 578.20922 226.8
[M+NH4]+ 597.25032 212.9
[M+K]+ 618.17966 213.8
[M+H-H2O]+ 562.21376 204.4
[M+HCOO]- 624.21470 223.5
[M+CH3COO]- 638.23035 219.0
[M+Na-2H]- 600.19117 205.9
[M]+ 579.21595 214.8
[M]- 579.21705 214.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe